CD44 and breast cancer: The above, along with our findings that SOD2 was significantly upregulated upon the interaction of CD44 with its major ligand HA [14]; prompted us to hypothesize that SOD2 might be a novel transcriptional target of CD44-downstream signaling, and thus, have a critical role in promoting BC tumor cell invasion and metastasis.